These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 9087167

  • 1. Modulation of Src homology 3 proteins by the proline-rich adaptor protein Shb.
    Karlsson T, Welsh M.
    Exp Cell Res; 1997 Mar 15; 231(2):269-75. PubMed ID: 9087167
    [Abstract] [Full Text] [Related]

  • 2. Shb is a ubiquitously expressed Src homology 2 protein.
    Welsh M, Mares J, Karlsson T, Lavergne C, Bréant B, Claesson-Welsh L.
    Oncogene; 1994 Jan 15; 9(1):19-27. PubMed ID: 8302579
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dominant-negative mutants of the SH2/SH3 adapters Nck and Grb2 inhibit MAP kinase activation and mesoderm-specific gene induction by eFGF in Xenopus.
    Gupta RW, Mayer BJ.
    Oncogene; 1998 Oct 29; 17(17):2155-65. PubMed ID: 9811447
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Shb promotes blood vessel formation in embryoid bodies by augmenting vascular endothelial growth factor receptor-2 and platelet-derived growth factor receptor-beta signaling.
    Rolny C, Lu L, Agren N, Nilsson I, Roe C, Webb GC, Welsh M.
    Exp Cell Res; 2005 Aug 15; 308(2):381-93. PubMed ID: 15919073
    [Abstract] [Full Text] [Related]

  • 9. STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation.
    Sachsenmaier C, Sadowski HB, Cooper JA.
    Oncogene; 1999 Jun 17; 18(24):3583-92. PubMed ID: 10380880
    [Abstract] [Full Text] [Related]

  • 10. Platelet-derived growth factor-mediated signaling through the Shb adaptor protein: effects on cytoskeletal organization.
    Hooshmand-Rad R, Lu L, Heldin CH, Claesson-Welsh L, Welsh M.
    Exp Cell Res; 2000 Jun 15; 257(2):245-54. PubMed ID: 10837138
    [Abstract] [Full Text] [Related]

  • 11. Reduced tumor growth in vivo and increased c-Abl activity in PC3 prostate cancer cells overexpressing the Shb adapter protein.
    Davoodpour P, Landström M, Welsh M.
    BMC Cancer; 2007 Aug 15; 7():161. PubMed ID: 17697368
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. c-Src activates both STAT1 and STAT3 in PDGF-stimulated NIH3T3 cells.
    Cirri P, Chiarugi P, Marra F, Raugei G, Camici G, Manao G, Ramponi G.
    Biochem Biophys Res Commun; 1997 Oct 20; 239(2):493-7. PubMed ID: 9344858
    [Abstract] [Full Text] [Related]

  • 16. Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway.
    Song JS, Haleem-Smith H, Arudchandran R, Gomez J, Scott PM, Mill JF, Tan TH, Rivera J.
    J Immunol; 1999 Jul 15; 163(2):802-10. PubMed ID: 10395673
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Isolation and characterization of e3B1, an eps8 binding protein that regulates cell growth.
    Biesova Z, Piccoli C, Wong WT.
    Oncogene; 1997 Jan 16; 14(2):233-41. PubMed ID: 9010225
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs).
    Wu CJ, Chen Z, Ullrich A, Greene MI, O'Rourke DM.
    Oncogene; 2000 Aug 17; 19(35):3999-4010. PubMed ID: 10962556
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.